Pre-planned feasibility and safety analyses of docetaxel/S-1 combination in a phase III study comparing docetaxel/S-1 with S-1 alone as postoperative adjuvant chemotherapy for stage III gastric cancer (JACCRO GC-07).

被引：1
|
作者：
Kakeji, Yoshihiro
Kodera, Yasuhiro
Yoshida, Kazuhiro
Kochi, Mitsugu
Takahashi, Masazumi
Kii, Takayuki
Ishiguro, Atsushi
Ishigure, Kiyoshi
Takagane, Akinori
Matsui, Takanori
Kaji, Masahide
Ichikawa, Wataru
Sano, Takeshi
Takeuchi, Masahiro
Fujii, Masashi
Nakajima, Toshifusa
机构：
[1] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4648601, Japan
[3] Gifu Univ, Sch Med, Gifu 500, Japan
[4] Nihon Univ, Sch Med, Tokyo, Japan
[5] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan
[6] Osaka Med Coll Hosp, Ctr Canc Chemotherapy, Osaka, Japan
[7] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan
[8] Konan Kosei Hosp, Konan, Japan
[9] Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan
[10] Aichi Canc Ctr Hosp, Okazaki, Aichi, Japan
[11] Toyama Prefectural Cent Hosp, Toyama, Japan
[12] Showa Univ, Tokyo, Japan
[13] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[14] Kitasato Univ, Tokyo, Japan
[15] Japan Clin Canc Res Org, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15000
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study
    Kunisaki, Chikara
    Ono, Hidetaka A.
    Hasegawa, Shinichi
    Oshima, Takashi
    Fujii, Shoichi
    Tokuhisa, Motohiko
    Izumisawa, Yusuke
    Takagawa, Ryo
    Kimura, Jun
    Kosaka, Takashi
    Makino, Hirochika
    Akiyama, Hirotoshi
    Endo, Itaru
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (06) : 364 - 372
  • [32] Comparison of S-1 and cisplatin combination versus S-1 adjuvant chemotherapy for advanced gastric cancer
    Kim, Hyo Song
    Jeung, Hei-Cheul
    Jung, Minkyu
    Kim, Hye Ryun
    Ahn, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial update.
    Fujii, M.
    Kim, Y. H.
    Satoh, T.
    Hosaka, H.
    Kim, T.
    Tsuji, A.
    Inokuchi, M.
    Takagane, A.
    Oh, S. C.
    Tanabe, K.
    Okuno, T.
    Chin, K.
    Ura, T.
    Lee, J. I.
    Kakudo, Y.
    Yamaguchi, K.
    Iijima, S.
    Takeuchi, M.
    Kim, H.
    Nakajima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] PHASE II STUDY WITH DOCETAXEL, OXALIPLATIN AND S-1 COMBINATION CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCER
    Zang, D. Y.
    Kang, Y.
    Ryoo, B.
    Ryu, M.
    Lee, S. S.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Kim, H. S.
    Choi, D. R.
    ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
  • [35] Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer
    Takahashi, I
    Emi, Y
    Kakeji, Y
    Tokunaga, E
    Ushiro, S
    Oki, E
    Watanabe, M
    Baba, H
    Maehara, Y
    ONCOLOGY REPORTS, 2006, 15 (04) : 849 - 854
  • [36] Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer
    Kasahara, Kohei
    Kunisaki, Chikara
    Sato, Sho
    Kondo, Hiroki
    Takahashi, Masazumi
    Tamura, Yuko
    Tsuchiya, Nobuhiro
    Tanaka, Yusaku
    Sato, Kei
    Kimura, Jun
    Kosaka, Takashi
    Ono, Hidetaka
    Makino, Hirochika
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2023, 43 (06) : 2841 - 2850
  • [37] Phase I/II study of new combination chemotherapy with docetaxel and S-1 for advanced gastric cancer
    Hyodo, Ichinosuke
    Yamaguchi, Kensei
    Saitoh, Soh
    Takiuchi, Hiroya
    Miyata, Yoshinori
    Sakata, Yuh
    ANNALS OF ONCOLOGY, 2004, 15 : 246 - 246
  • [38] Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).
    Lee, Choong-kun
    Jung, Minkyu
    Kang, Seok Yun
    Kim, Bong-Seog
    Kim, Ki Hyang
    Lee, Kyung Hee
    Lee, Moon Hee
    Shin, Dong Bok
    Zang, Dae Young
    Ahn, Ji Yeong
    Kim, Hyoung-il
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study (vol 26, 1063, 2023)
    Kodera, Yasuhiro
    Yoshida, Kazuhiro
    Kochi, Mitsugu
    Sano, Takeshi
    Ichikawa, Wataru
    Kakeji, Yoshihiro
    Sunakawa, Yu
    Takeuchi, Masahiro
    Fujii, Masashi
    GASTRIC CANCER, 2024, 27 (05) : 1157 - 1157
  • [40] Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial
    Hu, Xiang
    Chen, Lin
    Du, Yian
    Fan, Biao
    Bu, Zhaode
    Wang, Xin
    Ye, Yingjiang
    Zhang, Zhongtao
    Xiao, Gang
    Li, Fei
    He, Qingsi
    Li, Guoli
    Shen, Xian
    Xiong, Bin
    Zhu, Liming
    Liu, Jiwei
    Liu, Lian
    Wu, Tao
    Zhou, Jing
    Zhang, Jun
    Zhao, Gang
    Wang, Xulin
    Liang, Pin
    Wang, Xinxin
    Zhang, Yan
    Wu, Xiaojiang
    Zhang, Ji
    Ji, Xin
    Zong, Xianglong
    Fu, Tao
    Jia, Ziyu
    Ji, Jiafu
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (02) : 144 - 148
12345